|Articles|July 1, 2015
Building Biopharmaceutical Manufacturing Processes
Brady Cole, VP of Commercial Operations, at ABEC, spoke with BioPharm International about biopharmaceutical manufacturing processes.
Advertisement
Brady Cole, VP of Commercial Operations, at ABEC, spoke with BioPharm International about biopharmaceutical manufacturing processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
2
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
Next-Generation Modalities Drive New Antibody Discovery
5